Associate Director-Investigator Engagement
Russell has 15+ years’ experience in preclinical oncology research prior to joining Lilly in 2014. In his current role his team is responsible for identifying, qualifying and selecting clinical trial sites in alignment with the strategy developed for the study and portfolio and delivering enrollment within the predetermined timeline. Our focus is on speed, quality, and understanding tactics that allow sites to be successful. To achieve our overall goal we place emphasis on developing strong relationships with our sites to deliver an exemplary patient experience and aim to be sponsor of choice with our clinical partners.